Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Checking The Pulse – Recent Legal Developments In The Indian Healthcare And Pharma Sector

    With 2024 coming to a close and 2025 starting to take shape, the healthcare and pharmaceutical sectors appear set to build on the positive momentum accumulated in the last year.
    IndiaFood, Drugs, Healthcare, Life Sciences
    CMS INDUSLAW
    CMS INDUSLAW
  • Article

    Checking The Pulse – Recent Legal Developments In The Indian Healthcare And Pharma Sector

    In the past couple of months, the healthcare and pharmaceutical sectors have undergone significant regulatory and policy shifts, highlighting a sustained focus on transparency, quality assurance, and industry facilitation.
    IndiaFood, Drugs, Healthcare, Life Sciences
CMS INDUSLAW
CMS INDUSLAW
  • Article

    National Ethical Guidelines For Biomedical Research Involving Children: ICMR

    In October 2017, the first National Ethical Guidelines for Biomedical Research Involving Children has been published by the division of publication and information on behalf of the Secretary...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Do We Need Patent Term Extension And Non-Patent Exclusivities For Pharmaceuticals?

    India, though in a phase of rapid economic development, still has the bane of poverty. In this country, around 22% of the population is Below the Poverty Line.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Online Pharmacies: Conundrum On Legality

    "It is easy to get a thousand prescriptions, but hard to get one single remedy" so goes a popular Chinese proverb which succinctly summaries the pharmacy market in India and the debate surrounding e-pharmacies.
    IndiaFood, Drugs, Healthcare, Life Sciences
    King, Stubb & Kasiva
    King, Stubb & Kasiva
  • Article

    Patenting Of Plants: A Boon Or A Bane?

    If a plant or seed is defined by a single DNA sequence developed by research, it has chances of being patented in many countries.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Covid-19 And Vaccines Regulatory Update: The Story Thus Far

    The outbreak of the COVID-19 pandemic has created a significant impact on the healthcare and pharmaceutical industries.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    Medical Device Monitor: March 2017

    Since the government declared medical devices as one of the 25 focus sectors in 2014, the industry has been undergoing significant changes in terms of new policy measures and strengthening of the regulatory framework.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    Medical Devices Regulation In India: Tracing Its Evolution To Gets Cues On Its Future Development

    The medical devices industry needs robust regulations.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Ikigai Law
    Ikigai Law
  • Article

    Medical Device Wrap – 2018: Looking Back To Look Beyond

    January 01, 2019 marked the first anniversary of the Medical Device Rules 2017 – India's first step in de-linking medical devices regulations from drugs.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    Patented New Drugs And Orphan Drugs Out Of Price Control In India

    The Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) has notified an order amending the Drugs (Prices Control) Order 2013.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    Overview – Regulatory Issues Surrounding Cultivated Meat

    Today, agriculture uses nearly half the world's vegetated land, comprises 90% of our water use and contributes to a quarter of global emissions to feed approximately 7 billion people.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Ikigai Law
    Ikigai Law
  • Article

    Medical Device Round Up: Key Developments In 2019

    Regulation of medical devices has speedily evolved in the preceding two years. Before the introduction of the Medical Device Rules, 2017 ("MDR 2017"), the regulation of medical devices
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    Production Linked Incentive (PLI) Scheme For Promotion Of Domestic Manufacturing Of Pharmaceuticals

    The AtmaNirbhar Bharat initiative continues to be a focus for the Government of India (GoI). The objective of this initiative is to make India increasingly self-sufficient and reduce dependence...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    World Wide Legal Status Of Medical Method Patents: An Overview

    Therapeutic, surgical and diagnostic methods produce effects on the human (or animal) body, and they don’t have an industrial effect.
    GlobalIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    India's Pharmacovigilance Regime

    ThePvPI is an administrative mechanism that has been developed for monitoring the safety of authorized medicinal products (for human use) and to detect any deviation in their risk-benefit balance.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Lifesciences And Healthcare Newsletter | July 2024

    Welcome to the July 2024 edition of our Life Sciences and Healthcare Newsletter, where we delve into the latest developments shaping the industry.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    Indian Government Initiatives To Boost Up "Make In India" Campaign In Biotechnology Sector

    Recently Prime Minister Mr Narendra Modi unveiled the "Make in India" campaign, with an aim to turn the country into a global manufacturing hub.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    DNA Profiling in India (Towards the New Age DNA Technology Use and Application Bill, 2018)

    A decade ago, the whole country was sent flying into a state of bewilderment by the news headlines flashing on the TV screens that morning.
    IndiaTechnology
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Corporate & Commercial Monthly Newsletter | June 2023

    An advisory was recently issued on the Goods and Services Tax Portal regarding the time limit for reporting invoices on the Invoice Registration Portal (IRP) for taxpayers with Annual Aggregate Turnover...
    IndiaCorporate/Commercial Law
    HSA Advocates
    HSA Advocates
  • Showing 341–360 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics